Table 1 Baseline characteristics of participants in the integrated and usual care groups according to follow-up status
Died during follow-up | Alive after two years of follow-up | ||||||
|---|---|---|---|---|---|---|---|
IC group | UC group | p-value | IC group | UC group | p-value | p - value | |
n = 35 | n = 21 | IC v UC | n = 51 | n = 49 | IC v UC | Died v Alive | |
Age, years, mean ± SD | 76.4 ± 9.6 | 74.7 ± 8.0 | 0.5 | 72.5 ± 9.0 | 73.1 ± 9.4 | 0.7 | 0.09 |
Sex: female, n (%) | 20 (57) | 13 (62) | 0.7 | 29 (57) | 27(55) | 0.8 | 1.0 |
Living arrangements: | |||||||
Living alone, n (%) | 15 (42.9) | 12 (57.1) | 0.3 | 29 (56.9) | 22 (44.9) | 0.2 | 0.7 |
Receiving home-care services, n (%) | 24 (58.5) | 17 (41.5) | 0.3 | 24 (48.0) | 20 (40.8) | 0.5 | 0.5 |
FEV1, litres, mean ± SD | 0.81 ± 0.4 | 0.75 ± 0.3 | 0.5 | 0.92 ± 0.35 | 0.84 ± 0.34 | 0.3 | 0.07 |
FEV1%, mean ± SD | 32.3 ± 10.5 | 31.7 ± 9.9 | 0.9 | 34.9 ± 9.4 | 33.4 ± 9.2 | 0.4 | 0.2 |
PaO2, kPa, mean ± SD | 8.04 ± 1.3 | 8.7 ± 1.7 | 0.1 | 9.0 ± 1.4 | 8.7 ± 1.2 | 0.3 | 0.3 |
PaCO 2,kPa, mean ± SD | 6.1 ± 1.3 | 6.2 ± 1.3 | 0.9 | 5.6 ± 0.8 | 5.7 ± 1.0 | 0.1 | 0.008 |
GOLD stage 4, n (%) | 14 (40) | 11 (52) | 0.4 | 20 (39) | 22 (45) | 0.6 | 0.5 |
BMI, kg/m2, mean ± SD | 21.6 ± 4.7 | 22.1 ± 6.5 | 0.8 | 23.9 ± 5.4 | 23.9 ± 4.6 | 0.9 | 0.05 |
Current smoker, n (%) | 10 (28.6) | 11 (52.4) | 0.08 | 18 (35.3) | 15 (30.6) | 0.8 | 0.6 |
Inhaled medication: | |||||||
LAMA | 13 (37.1) | 11 (52.4) | 0.3 | 20 (39.2) | 25 (51) | 0.2 | 0.8 |
LABA + ICS | 25 (71.4) | 17 (81.0) | 0.4 | 36 (70.6) | 35 (71.4) | 0.9 | 0.6 |
HA one year prior to study start, median (IQR) | 2 (1, 3) | 2 (1, 3) | 0.6 | 1.0 (1, 1) | 1.0 (1, 2) | 0.03 | 0.01 |
HD one year prior to study start, median (IQR) | 9 (6, 22) | 11 (7.5, 18.5) | 0.9 | 7 (4, 11) | 8 (5, 13) | 0.2 | 0.003 |